Related Experiment Video

Updated: Jun 10, 2025

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.0K

DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient

Bac Viet Le, Umeshkumar Vekariya, Monika M Toma

    Biorxiv : the Preprint Server for Biology
    |October 16, 2024
    PubMed

    Insights

    DNA polymerase theta (Polθ) is crucial for myeloid malignancies with DNMT3A mutations (DNMT3Amut). Inhibiting Polθ enhances standard therapies, offering a new therapeutic strategy for these resistant leukemia types.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Myeloid malignancies with DNMT3A mutations (DNMT3Amut) exhibit resistance to conventional treatments.
    • DNMT3Amut leukemia cells accumulate DNA damage, increasing reliance on DNA damage response (DDR) pathways.
    • DNA polymerase theta (Polθ) is vital for the survival and proliferation of DNMT3Amut leukemia cells.

    Purpose of the Study:

    • To investigate the role of DNA polymerase theta (Polθ) in DNMT3Amut myeloid malignancies.
    • To explore Polθ as a potential therapeutic target in resistant leukemia.
    • To understand the mechanisms regulating Polθ expression and activity in DNMT3Amut leukemia.

    Main Methods:

    • Analysis of Polθ overexpression in DNMT3Amut leukemia cells.
    • Investigation of the PARP1-UBE2O pathway regulating Polθ degradation.
    • Assessment of Polθ's role in DNA double-strand break repair and replication fork restart.
    • Evaluation of Polθ inhibitors in combination with standard therapies in vitro and in vivo.

    Main Results:

    • Polθ is overexpressed in DNMT3Amut leukemia due to impaired proteasomal degradation.
    • DNMT3Amut leukemia cells show diminished recruitment of repressive complexes to DNA damage sites, facilitating Polθ loading.
    • Polθ inhibition synergizes with FLT3 inhibitors (quizartinib), cytarabine, and etoposide to reduce leukemia cell viability and tumor burden.
    • Polθ inhibition demonstrates anti-leukemic effects in preclinical models of FLT3(ITD);DNMT3Amut leukemia.

    Conclusions:

    • DNA polymerase theta (Polθ) is essential for DNMT3Amut myeloid malignancies.
    • Targeting Polθ represents a promising therapeutic strategy to overcome resistance in DNMT3Amut hematological malignancies.
    • Combination therapies involving Polθ inhibitors may enhance treatment efficacy for patients with these aggressive leukemias.

    More Related Videos

    Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response05:01

    Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response

    Published on: June 14, 2024

    1.2K
    Proofreading and DNA Repair Assay Using Single Nucleotide Extension and MALDI-TOF Mass Spectrometry Analysis11:08

    Proofreading and DNA Repair Assay Using Single Nucleotide Extension and MALDI-TOF Mass Spectrometry Analysis

    Published on: June 19, 2018

    9.7K

    Related Concept Videos

    Translesion DNA Polymerases02:10

    Translesion DNA Polymerases

    Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
    TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
    9.9K
    Nucleotide Excision Repair01:38

    Nucleotide Excision Repair

    DNA Distortion and Damage
    Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
    3.5K
    Overview of DNA Repair02:25

    Overview of DNA Repair

    In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
    Chemically...
    30.7K
    Fixing Double-strand Breaks02:04

    Fixing Double-strand Breaks

    The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
    12.5K
    DNA Damage can Stall the Cell Cycle02:37

    DNA Damage can Stall the Cell Cycle

    In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
    9.1K
    Long-patch Base Excision Repair01:02

    Long-patch Base Excision Repair

    Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
    7.0K